Long vs short acting testosterone treatments: A look at the risks

AA Gurayah, A Dullea, A Weber, JM Masterson… - Urology, 2023 - Elsevier
Prescriptions for testosterone therapy (TT) to treat testosterone deficiency have increased in
recent years. The purpose of this review was to evaluate the risks of several treatment …

Genetic determinants of plasma testosterone in male blood donors are associated with altered red blood cell characteristics and survival in cold storage and after …

F Fang, NH Roubinian, SW Bean, C Kemmler… - … and Apheresis Science, 2024 - Elsevier
Genetic mutations in genes regulating plasma testosterone in men may interfere with
effective erythropoiesis, and may result in red blood cell (RBC) dysfunction and hemolysis …

Testosterone supplementation increases red blood cell susceptibility to oxidative stress, decreases membrane deformability, and decreases survival after cold storage …

J Tran, RP Jackman, MO Muench, K Hazegh… - …, 2024 - Wiley Online Library
Background Blood collection from donors on testosterone therapy (TT) is restricted to red
blood cell (RBC) concentrates to avoid patient exposure to supraphysiological testosterone …

Hypogonadism is frequent in very old men with multimorbidity and is associated with anemia and sarcopenia

S Schluessel, M Bidlingmaier, S Martini… - … für Gerontologie und …, 2024 - Springer
Background Clinical data regarding hypogonadism in very old men with multimorbidity are
rare. Hypogonadism can contribute to osteoporosis, anemia and sarcopenia and is therefore …

Supporting Transgender, Nonbinary, and Gender Diverse Youth During Solid Organ Transplantation

K Alexander, J Goodall, BJ Allen - Pediatric Transplantation, 2025 - Wiley Online Library
As gender diversity becomes more understood and accepted in mainstream culture, medical
systems and health care providers must learn to provide comprehensive and affirming care …

Management of erythrocytosis in men receiving testosterone therapy: clinical consultation guide

P Agrawal, SM Singh, T Kohn - European Urology Focus, 2023 - Elsevier
Conclusions Erythrocytosis is the most common side effect of all TT modalities. Patient-
specific factors should be considered when choosing an appropriate TT dosage and …

Rises in Hematocrit is Associated with an Increased Risk of Major Adverse Cardiac Events in Men Starting Testosterone Therapy-A Retrospective Cohort Claims …

TP Kohn, P Agrawal, J Ory, J Hare… - Journal of Urology, 2023 - journals.lww.com
Objective: Elevated hematocrit (Hct) can result in increased risk of major adverse cardiac
events (MACE) in men receiving testosterone therapy (TTh). However, the impact of the …

[HTML][HTML] Prevalence of secondary erythrocytosis in men receiving testosterone therapy: A matched-cohort analysis of intranasal gel, injections, and pellets

R Reddy, P Diaz, R Blachman-Braun… - Canadian Urological …, 2023 - ncbi.nlm.nih.gov
METHODS We conducted a single-center, retrospective, matched-cohort study of patients
treated for testosterone deficiency (TD) to investigate the effect of three TTh regimens on …

Tetraselmis chuii y rendimiento deportivo

ÁG García Rodríguez - 2023 - dehesa.unex.es
El objetivo de este trabajo fue evaluar los efectos de la suplementación con microalgas
Tetraselmis chuii (TC) durante sesenta días sobre parámetros relacionados con la …

[HTML][HTML] The Safety of Human Chorionic Gonadotropin Monotherapy Among Men With Previous Exogenous Testosterone Use

Q Rainer, R Pai, I Zucker, R Ramasamy, TA Masterson - Cureus, 2022 - ncbi.nlm.nih.gov
Results Among the entire cohort, we found no significant change in mean hormone levels
(including T), HbA1c, or PSA. There was a significant (p< 0.05) decrease in HCT …